Gujarat Kidney IPO: Opening Dates and Subscription Timeline


Gujarat Kidney & Super Speciality is going to make a big entrance into the market! Public subscription for the company’s IPO starts on Monday, December 22, 2025, and will last for just three days, closing on December 24, 2025, which is very quick and full of action. Investors now have a golden opportunity to have a piece of this growing healthcare giant.


The IPO goes to the heart of the matter since the company operates multispeciality hospitals, pharmacies, and has nearly 490 beds in total across Gujarat. This IPO is going to be very attractive to both retail and institutional investors. Make sure you are not late because if you do not pay attention during these three days, you might miss the most talked-about healthcare listing of the year!










Gujarat Kidney IPO: Offer Details, Objectives, And Price Band
































































CategoryDetails
IPO OfferBook-built public issue of up to 2,20,00,000 equity shares
Face Value₹2 per share
Total Amount to RaiseNot disclosed in the RHP
Objective of IPOFunds Utilization:
₹77 crore – Acquisition of Parekhs Hospital, Ahmedabad
₹12.40 crore – Part-payment of Ashwini Medical Centre
₹10.78 crore – Additional shares in Harmony Medicare Pvt. Ltd
₹30.09 crore – Capex for new hospital in Vadodara
₹6.82 crore – Robotics equipment
₹1.20 crore – Loan repayment
Remaining – General corporate purposes
Price Band₹108-114 per share
Lot Size128 shares per lot






Grey Market Premium (GMP) Of Gujarat Kidney IPO


As of Saturday, 20 December 2025, the GMP of Gujarat Kidney IPO stood at ₹7 per share. With the upper price band at ₹114, the listing price is expected around ₹121, indicating a 6% listing premium.






















  • Qualified Institutional Buyers (QIBs): Minimum 75% of the issue




  • Non-Institutional Investors (NIIs): Maximum 15% of the issue




  • Retail Investors: Maximum 10% of the issue




  • Book-Running Manager: Nirbhay Capital Services




  • Registrar of the Offer: MUFG Intime India Pvt. Ltd (formerly Link Intime India Pvt. Ltd)















(With Inputs)










Aishwarya Samant



Aishwarya is a journalism graduate with over three years of experience thriving in the buzzing corporate media world. She’s got a knack for decoding business news, tracking the twists and turns of the stock market, covering the masala of the entertainment world, and sometimes her stories come with just the right sprinkle of political commentary. She has worked with several organizations, interned at ZEE and gained professional skills at TV9 and News24, And now is learning and writing at NewsX, she’s no stranger to the newsroom hustle. Her storytelling style is fast-paced, creative, and perfectly tailored to connect with both the platform and its audience. Moto: Approaching every story from the reader’s point of view, backing up her insights with solid facts.

Always bold with her opinions, she also never misses the chance to weave in expert voices, keeping things balanced and insightful. In short, Aishwarya brings a fresh, sharp, and fact-driven voice to every story she touches.




www.newsx.com/business/





The post How Gujarat Kidney IPO Is Set To Transform Healthcare Investments In India: Key Dates, Offer Details, And Investor Insights appeared first on NewsX.


Contact to : xlf550402@gmail.com


Privacy Agreement

Copyright © boyuanhulian 2020 - 2023. All Right Reserved.